FAFTFSNP
VRTX icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Vertex Pharmaceuticals VRTX Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$33.4M Buy
+71,188
New +$30.9M 0.38% 44

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s VRTX Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2024: 71,188 shares worth $33.4M. The stake represents 0.38% of the portfolio and ranks #44 among its holdings.

1,547 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 71,188 shares of Vertex Pharmaceuticals worth $33.4M as of Q2 2024.
  • Vertex Pharmaceuticals was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Vertex Pharmaceuticals made up 0.38% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #44 holding.
  • 1,547 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.